* Data users need to apply the Form 2 (Application Form for Using NBDC Human Data) to reach the Controlled-Access Data. Learn more
Research ID | Study Title | Release Date | Type of Study | Platform |
Participants/Materials (Ethnicity) | Data Provider | Type of Data |
---|---|---|---|---|---|---|---|
JGAS000002 |
Sequence Data of a SCA31 Patient |
v1:2013/12/01 |
Single Patient NGS (WGS) |
Illumina (HiSeq 2000) |
1 Patient (Japanese) |
Shinichi Morishita |
Controlled-Access (Type I) |
JGAS000001 |
Molecular Epidemiological Study of Somatic Mutation Profiles of EGFR Mutation Positive Lung Adenocarcinoma |
v1:2014/07/11 |
NGS (Exome) |
Illumina (Genome Analyzer IIx) |
97 Patients (Japanese) |
Koichi Goto |
Controlled-Access (Type I) |
DRA001273 JGAS000032 DRA003791 JGAS000093 JGAS000123 JGAS000166 |
Genetic Analysis of Hearing Loss and Its Clinical Application |
v1:2014/01/27 v2:2017/02/24 v3:2017/06/19 v4:2018/02/13 v5:2019/04/18 |
NGS (Target Capture) |
Life technoligies (Ion PGM/IonProton) Illumina (HiSeq 2000) |
17 UsherSyndrome patients 121 Non-syndromic hearing loss patients (Japanese) |
Shin-ichi Usami |
Un-restricted Access Controlled-Access (Type I) |
JGAS000004 JGAS000106 JGAS000146 |
Genomic and Genetic Analysis of Brain Tumors and Analysis of Their Clinicopathological Significance |
v1:2014/01/31 v2:2017/06/05 v3:2017/09/01 v4:2019/02/13 |
NGS (Exome, RNA-seq) Methylation array |
Illumina (HiSeq 2000, HumanMethylation450 BeadChip) |
6 astrocytomas 16 oligodendrogliomas gliomas (17 cerebellar gliomas, 8 cerebral glioblastomas and 14 thalamic gliomas) 94 gliomas (Japanese) |
Nobuhito Saito (P-DIRECT) |
Controlled-Access (Type I) |
JGAS000005 |
Gene Expression of Human Th17 Cells Before and After Activation |
v1:2015/02/12 |
NGS (RNA-seq) |
Applied BioSystems (AB5500 GA) |
1 Participant (4 Samples) (Japanese) |
Sanju Iwamoto |
Controlled-Access (Type I) |
JGAS000007 |
Research for genetic causes and mechanisms of Hirschsprung's
|
v1:2018/01/29 |
NGS (Exome) |
Illumina (HiSeq 2000) |
5 Patients with Hirschsprung's diseases and 6 their families (Japanese) |
Hiroshi Matsufuji |
Controlled-Access (Type I) |
DRA003802 |
DNA Methylation Analysis of Early Human Embryos |
v1:2014/12/24 v2:2015/01/07 v3:2015/08/03 |
NGS (PBAT) |
Illumina (HiSeq 2000/2500) |
11 Libraries (Japanese) |
Takahiro Arima |
Un-restricted Access |
JGAS000008 |
Research for candidate genes of splenic epidermoid cyst. |
v1:2015/06/23 |
NGS (Exome) |
Illumina (HiSeq 2000) |
8 Splenic epidermoid cysts (Japanese) |
Hiroshi Matsufuji |
Controlled-Access (Type I) |
JGAS000015 |
Integrated hepatitis B virus is epigenomically regulated by the methylation status of the human genome |
v1:2015/10/07 |
NGS (Target Capture) |
Roche GS FLX Titanium |
2 Cell lines 8 HB-HCC primary tissues (Japanese) |
Hiroyuki Yamamoto |
Controlled-Access (Type I) |
JGAS000012 |
Nagahama Zero-ji Preventive Cohort Project |
v1:2015/08/19 |
SNP-chip Control Set Cohort |
Illumina (Human610-Quad, HumanOmni2.5-4/2.5-8/2.5S-8, HumanExome-12, HumanCoreExome-12) |
3712 Participants (Japanese) |
Fumihiko Matsuda |
Controlled-Access (Type I) |
Japan PGx Data Science Consortium Database |
v1:2014/10/16 |
SNP-chip Control Set |
Illumina (HumanOmni2.5-8) |
2994 Participants (Japanese) |
Koji Suematsu |
Un-restricted Access |
|
JGAS000101 JGAS000114 JGAS000140 JGAS000203 |
Bio Bank Japan project |
v1:2014/09/30 v2:2015/12/28 v3:2016/01/28 v4:2016/02/02 v5:2017/05/18 v6:2017/09/08 v7:2018/04/04 v8:2018/05/01 v9:2018/08/07 v10:2018/08/13 v11:2018/10/16 v12:2018/12/10 v13:2019/01/25 v14:2019/03/26 v15:2019/09/27 v16:2019/10/07 v17:2019/10/08 v18:2019/11/26 v19:2020/04/20 v20:2020/08/17 v21:2020/08/25 |
SNP-chip Case-Control NGS (WGS, Target Capture) |
Illumina (Human610-Quad, HumanHap550v3, HumanOmniExpress-12, HumanExome, OmniExpressExome, HiSeq 2500) Perlegen Sciences (high-density oligonucleotide arrays) Hologic Japan (Invader) |
1666 MIs and 3198 ctrls 934 ctrls (JSNP) 35 diseases (JSNP) 182 esophageal cancers (JSNP) 92 ALSs (JSNP) 9817 T2DMs and 6763 ctrls 5646 T2DMs and 19,420 ctrls 1472 ADs and 7966 ctrls 8180 AFs and 28,612 ctrls 158,284 individuals for BMI study 182,505 individuals' genotype data 3980 POAGs and 18,815 ctrls 162,255 individuals for 58 quantitative traits study 67,029 females with information on age at menarche 43,861 females with information on age at menopause 1,026 individuals for WGS 7,104 breast cancer patients and 23,731 controls 2,809 T2DM with diabetic nephropathy patients and 5,592 T2DM ctrls 36,614 T2DMs and 155,150 ctrls 165,436 individuals with information on smoking behaviour 1,026 individuals from biobank Japan and 2,504 individuals from 1KGP p3v5 ALL 159,095 individuals for height study 7,636 prostate cancer patients and 12,366 ctrls 212,453 individuals for 42 diseases 165,084 individuals with information on dietary habits 25,892 CADs and 142,336 ctrls (Japanese) |
Michiaki Kubo |
Un-restricted Access Controlled-Access (Type I) |
JGAS000159 |
Construction of the Whole-genome Reference Panel of 3552 Japanese Individuals |
v1:2014/10/14 v2:2018/12/27 v3:2019/01/11 |
NGS (WGS) |
Illumina (HiSeq 2500) |
3552 Participants (Japanese) |
Masayuki Yamamoto (ToMMo) |
Un-restricted Access |
DRA002604 |
Epigenome analysis of proteins expressed in human testis |
v1:2016/09/30 |
NGS (ChIP-seq, RNA-seq) |
Illumina (HiSeq 1500) |
1 Participant (4 Samples) (Japanese) |
Yasuyuki Ohkawa |
Un-restricted Access |
JGAS000021 |
Exome sequencing of primary central nervous system lymphoma |
v1:2016/02/22 |
NGS (Exome, RNA-seq) |
Illumina (HiSeq 2000) |
41 PCNSLs (Japanese) |
Hiroyuki Mano |
Controlled-Access (Type I) |
JGAS000009 |
Genetic analysis in neurodegenerative disorders |
v1:2015/02/03 |
NGS (Exome) |
Illumina (HiSeq 2000) |
14 MSAs and 7 Controls (Japanese) |
Shoji Tsuji |
Controlled-Access (Type I) |
JGAS000011 |
Systematic identification of long non-coding RNAs potentially involved in gastrointestinal cancer |
v1:2015/04/01 |
NGS (RNA-seq) Tumor vs. Matched-Normal |
Illumina (HiSeq 2500) |
17 GICs (32 Samples) (Japanese) |
Yasuhisa Shinomura (Genome Science) |
Controlled-Access (Type I) |
JGAS000013 |
Genetic Analysis in Amyotrophic Lateral Sclerosis |
v1:2015/01/08 |
NGS (Exome) |
Illumina (HiSeq 2000) |
11 ALSs (Japanese) |
Fumiaki Tanaka (Genome Science) |
Controlled-Access (Type I) |
JGAS000014 |
Genetic Analysis in Psychiatric Disorders |
v1:2015/01/08 |
NGS (Exome) |
Illumina (HiSeq 2000) |
Healthy Monozygotic Twins 3 Pairs [6 Participants] (Japanese) |
Tadafumi Kato (Genome Science) |
Controlled-Access (Type I) |
JGAS000017 |
Analysis of the Molecular Mechanism for Developing Donor-Origin Leukemia after Allogeneic Stem Cell Transplantation. |
v1:2015/02/02 |
NGS (Exome) |
Illumina (HiSeq 2000) |
1 DCL (5 Samples from Each Stage) 1 Donor (Japanese) |
Hitoshi Kiyoi (P-DIRECT) |
Controlled-Access (Type I) |
JGAS000016 |
Genetic Analysis in Lifestyle-Related Disease, Arteriosclerotic Disease, and Aging-Related Diseases |
v1:2015/01/28 |
NGS (Exome) |
Illumina (HiSeq 2000) |
30 Hypertensions (Japanese) |
Tetsurou Miki (Genome Science) |
Controlled-Access (Type I) |
JGAS000023 |
Comprehensive Analysis of Genetic Alterations in Hematological Malignancies |
v1:2015/04/16 |
NGS (Exome) |
Illumina (Genome Analyzer IIx, HiSeq 2000/2500) |
13 MDSs and 1 CMML (Japanese) |
Seishi Ogawa (P-DIRECT) |
Controlled-Access (Type I) |
JGAS000024 JGAS000040 |
Identification of genetic polymorphism on aggressive periodontitis |
v1:2016/07/28 |
NGS (Exome) |
Illumina (HiSeq 2000) |
Periodontitis patients (Japanese) |
Shinya Murakami |
Controlled-Access (Type I) |
JGAS000018 |
Biobank Japan Project |
v1:2015/06/02 v2:2018/06/05 |
SNP-chip |
Illumina (HumanOmniExpress BeadChip, HumanExome BeadChip, ImmunoChip, HumanHap550v3 Genotyping BeadChip) |
908 Participants (Japanese) |
Michiaki Kubo (BBJ) |
Controlled-Access (Type I) |
Study of Genome Polymorphism/Variation on Stevens-Johnson Syndrome |
v1:2016/03/09 v1:2020/12/21 |
SNP-chip Case-Control |
Affymetrix (Axiom ASI) Illumina (HiSeq X Ten) |
117 SJSs and 691 controls 133 SJS/TENs and 418 controls (Japanese) |
Mayumi Ueta (Genome Science) |
Un-restricted Access |
|
JGAS000022 |
The Molecular Biological Analysis about Occurrence and Malignant Transformation in gynecological carcinogenesis |
v1:2015/04/21 |
SNP-chip CNV Analysis |
Affymetrix (Human Mapping 250K Nsp Array) |
57 OvarianCarcinomas (Japanese) |
Katsutoshi Oda (P-DIRECT) |
Controlled-Access (Type I) |
JGAS000042 |
Constructing database of magnetic resonance imaging of the brain and the ancillary clinical information for multisite collaboration studies |
v1:2015/11/20 |
Neuroimage Clinical Info |
Philips (Achieva) |
129 normal controls, 37 schizophrenia, 8 unipolar and 2 bipolar disorders (Japanese) |
Kiyoto Kasai |
Controlled-Access (Type I) Un-restricted Access |
JGAS000026 JGAS000027 JGAS000028 |
Standard epigenome mapping in human epithelial cells of the digestive and urogenital organs (HPC series) |
v1:2016/07/22 |
NGS (WGBS ChIP-seq RNA-seq) |
Illumina (HiSeq 2000/2500) |
8 partial hepatectomy specimens (Japanese) |
Yae Kanai (IHEC) |
Controlled-Access (Type I) |
DRA003516 |
Functional analysis of two types of exosome in human whole saliva |
v1:2015/05/01 |
NGS (RNA-seq) |
Illumina (Genome Analyzer IIx) |
1 Participant (3 Samples) (Japanese) |
Ryohei Yanoshita |
Un-restricted Access |
JGAS000037 |
Identification of novel therapeutic targets of small cell lung cancer by comprehensive genomic analyses |
v1:2015/10/01 |
NGS (Exome) |
Illumina (HiSeq 2000) |
51 SCLCs (Japanese) |
Koichi Goto (P-DIRECT) |
Controlled-Access (Type I) |
JGAS000036 JGAS000046 JGAS000088 JGAS000188 JGAS000204 JGAS000246 |
Genome wide analysis of gene mutations in solid tumors |
v1:2015/09/16 v2:2017/12/26 v3:2020/05/29 v4:2020/12/14 v5:2020/12/18 |
NGS (Exome, Target Capture, RNA-seq) SNP-chip Methylation array |
Illumina (HiSeq 2000/2500, MiSeq, Infinium MethylationEPIC) Affymetrix (GeneChip Human Mapping 250k Nspl, CytoScan HD arrays) |
16 RMSs 7 PPBs 522 NBs 39 neuroblastoma cell lines 10 PBLs 59 HBLs 2 HBL cell lines 51 patients with pediatric germ cell tumors 30 patients with high-risk neuroblastoma (Japanese) |
Junko Takita (P-DIRECT) |
Controlled-Access (Type I) |
DRA003736 |
Performance Comparison of Four Commercial Human Whole-Exome Capture Platforms |
v1:2015/08/01 |
NGS (Exome) Platform comparison |
Illumina (HiSeq 2500) |
2 HapMap-JPT samples (Japanese) |
Michiaki Kubo |
Un-restricted Access |
JGAS000035 |
Diagnostic feasibility study for pathological prediction with rheumatoid arthritis-susceptible genes and genomic regions identified by the association analysis using microsatelite markers |
v1:2015/09/24 |
NGS (Exome) |
Illumina (HiSeq 2000) |
39 RAs 10 Controls (pooled) (Japanese) |
Shigeki Mitsunagai (Genome Science) |
Controlled-Access (Type I) |
JGAS000041 |
Genetic analysis in an inherited cardiac arrhythmia |
v1:2015/11/18 |
NGS (Exome) |
Illumina (HiSeq 2000) |
11 Patients with an inherited cardiac arrhythmia (Japanese) |
Naomasa Makita (Genome Science) |
Controlled-Access (Type I) |
JGAS000039 |
Analysis of TKI resistant mechanism for gastrointstinal stromal tumor (GIST) |
v1:2016/12/27 |
NGS (Exome) |
Illumina (HiSeq 1500) |
4 Imatinib resistant GIST (Japanese) |
Tsuyoshi Takahashi |
Controlled-Access (Type I) |
JGAS000038 |
Epigenomic analysis of the human placenta |
v1:2016/09/16 |
NGS (WGS, Exome, RNA-seq, BS-seq) |
Illumina (HiSeq 2500) |
28 human placenta 26 maternal blood samples (Japanese) |
Takahiro Arima (IHEC) |
Controlled-Access (Type I) |
JGAS000052 |
Research of factors related to diagnosis, progression, prognosis and treatment of hepato-biliary-pancreatic malignancies |
v1:2017/01/12 |
NGS (Exome, Target Capture) |
Illumina (HiSeq 2000) |
33 primary HCC (Japanese) |
Shinji Tanaka (P-DIRECT) |
Controlled-Access (Type I) |
Genome analysis for elucidation of genetic factors in orofacial traits and diseases |
v1:2016/03/02 |
NGS (WGS) |
Illumina (HumanOmniExpress BeadChip) |
146 TMJ and 374 controls 149 third molar agenesis and 338 controls (Japanese, Korean) |
Tetsutarou Yamaguchi (Genome Science) |
Controlled-Access (Type I) |
|
JGAS000051 |
Japanese Alzheimer's disease neuroimaging initiative (J-ADNI) |
v1:2016/01/29 |
Neuroimage Clinical Info |
234 MCI 154 AD 149 healthly controls (Japanese) |
Takeshi Iwatsubo |
Controlled-Access (Type I) Un-restricted Access |
|
DRA004162 |
Research about retrovirus infection |
v1:2016/10/31 |
NGS (ChIP-seq) |
Illumina (NextSeq 500) |
1 ED (ATL cell line) (Cell-line) |
Yorifumi Satou |
Un-restricted Access |
JGAS000047 |
Transcriptome analysis of acute lymphoblastic leukemia in adolescents and young adults |
v1:2016/03/29 |
NGS (RNA-seq) |
Illumina (HiSeq 2000/2500) |
99 Ph(-) ALL 3 Ph(+) ALL 5 cell lines 8 normal hematopoietic cells (Japanese) |
Hiroyuki Mano (P-DIRECT) |
Controlled-Access (Type I) |
DRA004251 |
Whole exome sequencing on ampullary carcinomas |
v1:2016/02/05 |
NGS (Exome) |
Illumina (HiSeq 2000/2500) |
60 Patients with ampullary cancer (28 Japanese patients and 32 American patients) |
Shinich Yachida |
Un-restricted Access |
JGAS000053 |
Transcriptome analysis of Hepatitis B for drug discovery and clinical applications |
v1:2016/09/30 |
NGS (CAGE-seq) |
Illumina (HiSeq 2000) |
8 HBV (Genotype C) positive patients (Japanese) |
Tomokazu Matsuura |
Controlled-Access (Type I) |
JGAS000062 JGAS000176 |
Identification of new molecular targets with profiling of malignant mesothelioma |
v1:2016/07/20 v2:2020/04/14 |
NGS (Exome, WGS) |
Illumina (HiSeq 2000/2500) 10x Genomics (Chromium Controller) |
38 Malignant pleural mesothelioma (Japanese) |
Takashi Nakano (P-DIRECT) |
Controlled-Access (Type I) |
JGAS000059 |
Genetic and epigentic analysis of non-alcoholic fatty liver disease |
v1:2017/02/20 |
NGS (RNA-seq) Methylation array |
Illumina (HiSeq 2500, Human Methylation 450K BeadChip) |
64 NAFLD patients (Japanese) |
Kikuko Hotta (Genome Science) |
Controlled-Access (Type I) |
Genome and Multi-layer omics reference panels using blood samples from a population-based cohort study |
v1:2018/03/30 |
NGS (WGS, WGBS, RNA-seq) |
Illumina (HiSeq 2500/X) |
197 participants (Japanese) |
Atsushi Shimizu |
Un-restricted Access |
|
JGAS000091 |
Identification of genetic mutations characteristic for recurrence and metastasis of colorectal cancer. |
v1:2018/04/06 |
NGS (Exome) |
Illumina (HiSeq 2000) |
89 colorectal cancers (Japanese) |
Toshiharu Yamaguchi (P-DIRECT) |
Controlled-Access (Type I) |
JGAS000104 |
Identification of genetic mutations characteristic for recurrence of serous ovarian cancer |
v1:2018/04/06 |
NGS (Exome) |
Illumina (HiSeq 2000) |
65 ovarian cancer (Japanese) |
Kazuyoshi Kato (P-DIRECT) |
Controlled-Access (Type I) |
JGAS000075 |
Identification of genetic mutations characteristic for recurrence and metastasis of breast cancer |
v1:2018/04/03 |
NGS (Exome) |
Illumina (HiSeq 2000) |
65 recurrent / metastatic breast cancer patients (Japanese) |
Yoshio Miki (P-DIRECT) |
Controlled-Access (Type I) |
JGAS000057 |
Searching causative genes of familial tumors using whole genome / exome sequencing |
v1:2017/02/20 |
NGS (Exome) |
Illumina (HiSeq 2000) |
Siblings developed multiple primary lung cancers (Japanese) |
Kikuya Kato |
Controlled-Access (Type I) |
JGAS000061 |
Construction of Geriatric Oncology Database for establishment of the Treatment Algorithm: Clinical Data and Questionnaire Survey Results in JapaneseElderly Cancer Patients Retrospective study |
v1:2016/08/26 |
Direct sequencing TaqMan qRT-PCR COBRA cDNA microarray Clinical data Treatment data |
GA 3130 LightCycler 480II Whole Human Genome Microarray 4x44K |
[GENOME] 106 colorectal cancer 62 gastric cancer 173 lung cancer [Retrospective] 313 colorectal cancer 166 gastric cancer 344 lung cancer 300 diabetes and nephropathy 357 cardiovascular disorder 49 respiratory dysfunction (Japanese) |
Masahiko Nishiyama |
Controlled-Access (Type I) |
JGAS000089 |
Shuttle system between petient-derived xenograft and ex vivo culture for innovative platform of evaluating drug sensitivity |
v1:2018/04/06 |
NGS (Exome) |
Illumina (HiSeq 2000) |
8 colorectal cancer 2 lung cancer 2 small cell carcinoma of uterine cervix (Japanese) |
Masahiro Inoue (P-DIRECT) |
Controlled-Access (Type I) |
JGAS000060 |
Investigating the mechanisms of tumor recurrence and metastasis by non-coding RNA |
v1:2016/08/01 |
NGS (Exome) |
Illumina (HiSeq 2000) |
9 colorectal carcinomas (Japanese) |
Koshi Mimori |
Controlled-Access (Type I) |
JGAS000076 |
Project for Development of Innovative Research on Cancer Therapeutics; identifiying the predictive factors for response to chemoherapy in ovarian cancer |
v1:2017/05/18 |
NGS (Exome) |
Illumina (HiSeq 2000) |
55 ovarian clear cell carcinoma patients (Japanese) |
Toru Sugiyama (P-DIRECT) |
Controlled-Access (Type I) |
JGAS000065 |
Cancer genomics for elucidation of molecular mechanisms of carcinogenecis and progression in lung cancer |
v1:2017/07/10 v2:2020/10/19 |
NGS (PCR amplicon Seq, WGS) |
Nanopore (MinION, PromethION) Illumina (NovaSeq 6000) |
8 + 21 lung adenocarcinoma patients (Japanese) |
Takashi Kono |
Controlled-Access (Type I) |
JGAS000064 |
RNA expression profiling of neuromuscular diseases and viral diseases |
v1:2016/12/09 |
NGS (small RNA-seq) |
Illumina (HiSeq 2500) |
3 Neuromuscular disease (control group) (Japanese) |
Takanori Yokota |
Controlled-Access (Type I) |
JGAS000115 |
Molecular analysis of Birt-Hogg-Dube syndrome: Identification of new diagnostic marker and therapeutic target |
v1:2018/05/11 |
NGS (Exome) |
Illumina (HiSeq 2000) |
15 Birt-Hogg-Dube associated kidney cancer (Japanese) |
Masahiro Yao (P-DIRECT) |
Controlled-Access (Type I) |
Identification and functional analyses of susceptibility genes to narcolepsy and other sleep disorders |
v1:2017/12/26 |
SNP-chip |
Affymetrix (SNP Array 6.0) |
409 narcolepsy patients 1562 controls (Japanese) 125 essential hypersomnia patients 562 controls (Japanese) |
Katsushi Tokunaga |
Unrestricted-access |
|
Genome-wide association studies on Hepatitis C virus-related diseases and construction of genome database |
v1:2018/02/27 v2:2018/09/25 |
SNP-chip |
Affymetrix (SNP Array 6.0, Axiom ASI) |
78 NVR, 64 VR, 51 SVR 107 patients with the decrease of PLT 196 patients without the decrease of PLT 94 HCV patients with an Hb reduction 209 HCV patients without Hb reduction 123 patients who developed HCC after eradication of HCV 333 patients who did not develop HCC after eradication of HCV (Japanese) |
Yasuhito Tanaka |
Unrestricted-access |
|
Search for susceptibility genes to hepatitis virus B-related diseases |
v1:2017/09/25 v2:2019/02/19 |
SNP-chip |
Affymetrix (SNP Array 6.0, Axiom ASI) |
181 HBV carriers 185 spontaneously HBV-resolved individuals 184 controls 473 HBV-positive HCC patients 516 HBV carriers (chronic hepatitis and asymptomatic carriers) (Japanese) |
Masashi Mizokami |
Unrestricted-access |
|
Genome-wide search for susceptibility genes to primary biliary chirrosis |
v1:2016/10/05 |
SNP-chip |
Affymetrix (Axiom ASI) |
487 PBCs 476 controls (Japanese) |
Minoru Nakamura |
Unrestricted-access |
|
JGAS000120 |
Genome-wide analysis of SNPs in Healthy Japanese |
v1:2017/09/26 v1:2017/10/03 |
SNP-chip Control Set |
Affymetrix (Axiom ASI/6.0) |
419 Participants (Japanese) |
Katsushi Tokunaga |
Unrestricted-access Controlled-Access (Type I) |
JGAS000070 |
Genome-wide analysis for biomarker exploration (lung cancer) |
v1:2016/10/28 |
NGS (CAGE-seq) |
Illumina (HiSeq 2500) |
97 lung cancer tissues (Japanese) |
Yoshihide Hayashizaki |
Controlled-Access (Type I) |
JGAS000108 |
Molecular biological research affecting on long-term treatment to malignant tumors derived from the chest or abdomen Genomic analysis of environment-associated tumors |
v1:2017/10/16 v1:2018/09/25 |
Array CGH, NGS (WGS, Target Capture, Exome) |
Illumina (MiSeq, HiSeq 4000/X Ten) |
72 malignant mesotheliomas (Japanese, Americans) |
Masaki Ohmuraya |
Controlled-Access (Type I) |
JGAS000073 JGAS000107 |
Epigenomic analysis of the human placenta and endometrium constituting the fetal-maternal interface |
v1:2017/09/25 v2:2017/12/26 v3:2018/06/26 |
NGS (WGBS ChIP-seq RNA-seq small RNA-seq) |
Illumina (HiSeq 1500/2500) |
placenta and uterus cells, trophoblast stem cells: total 39 samples (Japanese) |
Hiroyuki Sasaki (IHEC) |
Controlled-Access (Type I) |
JGAS000077 JGAS000096 |
Global analysis of TGF-beta family signaling in cancer cells |
v1:2019/02/08 v2:2019/09/10 |
NGS (RNA-seq, WGS) |
Illumina (Genome Analyzer IIx) Thermo Fisher Scientific (Ion Proton) |
2 glioblastomas (Japanese) |
Kohei Miyazono |
Controlled-Access (Type I) |
JGAS000078 JGAS000079 JGAS000080 |
Study of molecular-genetics, and molecular epidemiology for developing treatment of esophageal cancer (COC series) |
v1:2016/11/18 |
NGS (WGBS ChIP-seq RNA-seq) |
Illumina (HiSeq 2000/2500) |
12 normal human absorptive epithelial cells (Japanese) |
Yae Kanai (IHEC) |
Controlled-Access (Type I) |
JGAS000095 JGAS000105 JGAS000113 JGAS000128 JGAS000215 |
Genomic and epigenomic analysis of different types of cancer |
v1:2017/09/04 v2:2018/01/22 v3:2019/02/12 v4:2020/08/14 v5:2020/10/26 |
NGS (WGS, Exome, RNA-seq), Methylation array, SNP-chip |
Illumina (HiSeq 2000/2500, Infinium Human MethylationEPIC BeadChip, HumanOmni2.5-8 BeadChip) |
68 breast cancer patients 43 + 126 lung adenocarcinoma patients 150 colorectal cancers 12 colorectal cancers with liver metastasis, 16 colorectal cancers without liver metastasis (Japanese) |
Hiroyuki Mano |
Controlled-Access (Type I) |
JGAS000092 |
Genetic analysis of colorectal precancerous lesion and early colorectal cancer to investigate mechanism of carcinogenesis of colorectal cancer |
v1:2018/07/30 |
NGS (Exome) |
Illumina (HiSeq 2500) |
10 cases of colorectal adenomas or PCRCs (Japanese) |
Koshi Mimori |
Controlled-Access (Type I) |
JGAS000090 JGAS000138 |
Comprehensive analysis of genetic alterations in hematological malignancies |
v1:2017/05/25 v2:2019/11/18 |
NGS (RNA-seq) Methylation array |
Illumina (HiSeq 2500, Infinium MethylationEPIC) |
123 pediatric T-ALL patients (Japanese) |
Junko Takita |
Controlled-Access (Type I) |
JGAS000094 |
Cytogenetic analysis of hematopoietic cells in bone marrow failure syndrome |
v1:2018/05/25 |
NGS (Exome) |
Illumina (HiSeq 2500) |
5 patients with aplastic anemia with uniparental disomy in 6p (Japanese) |
Shinji Nakao (Genome Science) |
Controlled-Access (Type I) |
JGAS000085 |
Expression quantitative trait loci analysis using human immune cells |
v1:2017/04/24 |
NGS (RNA-seq) SNP-chip |
Illumina (HiSeq 2500, Infinium OmniExpressExome BeadChips) |
105 healthy volunteers (Japanese) |
Kazuhiko Yamamoto |
Unrestricted-access Controlled-Access (Type I) |
JGAS000098 |
Identification of gene mutations in primary immunodeficiency characterized by EBV-associated B-cell lymphoma |
v1:2018/05/11 |
NGS (Target Capture) |
Illumina (MiSeq) |
2 patients with primary immunodeficiency (Japanese) |
Yasumasa Iwatani |
Controlled-Access (Type I) |
JGAS000109 |
Genome sequencing analysis for biliary tract cancer |
v1:2018/02/27 v2:2019/06/21 |
NGS (WGS, Exome) |
Illumina (HiSeq 2000/2500, NovaSeq 6000) |
98 biliary tract cancers (Japanese) |
Hidewaki Nakagawa |
Controlled-Access (Type I) |
JGAS000099 JGAS000218 |
Establish induced pluripotent stem (iPS) cells from patients with Gorlin syndrome and elucidate the pathology |
v1:2017/10/02 v2:2020/06/01 |
NGS (Exome, RNA-seq) |
Illumina (HiSeq 2500/4000) |
4 patients with Gorlin syndrome (Japanese) |
Toshifumi Azuma |
Controlled-Access (Type I) |
JGAS000111 |
Search for new susceptibility genetic factors associated with psychiatric disorders |
v1:2017/06/26 |
Methylation array |
Illumina (Infinium HumanMethylation450) |
48 panic disorder patients 48 healthy controls (Japanese) |
Katsushi Tokunaga |
Controlled-Access (Type I) |
JGAS000103 JGAS000141 |
Analysis of gastric cancer genome and its clinicopathological significance |
v1:2017/07/31 v2:2019/05/31 |
NGS (RNA-seq, Amplicon-seq) |
Illumina (HiSeq 2000, MiSeq) |
30 diffuse-type gastric carcinomas 60 gastric carcinomas (Japanese) |
Shumpei Ishikawa |
Controlled-Access (Type I) |
JGAS000112 (JGA000122) |
Basic research for the establishment and characterization of human trophoblast stem cells |
v1:2017/12/14 |
NGS (WGBS ChIP-seq RNA-seq miRNA-seq) |
Illumina (HiSeq 1500/2500) |
2 trophoblast stem cells (Japanese) |
Takahiro Arima |
Controlled-Access (Type I) |
JGAS000119 |
Development of metabolite biomarkers of Parkinson’s disease and identification of drug seeds from chemical screening based on the biomarkers |
v1:2020/04/24 |
NGS (CAGE-seq) |
Illumina (HiSeq 2500) |
39 PD patients, 20 non-PD (healthy) contorols (Japanese) |
Piero Carninci |
Controlled-Access (Type I) |
DRA007411 |
Research on statistical genetics using B cell lines of Japanese ancestry |
v1:2017/12/18 v2:2019/04/12 |
SNP-chip NGS (Target Capture) |
Illumina (HumanCoreExome BeadChip, MiSeq) |
282 psoriasis patients 426 controls 560 samples (Japanese) |
Yukinori Okada |
Unrestricted-access |
JGAS000121 DRA006296 |
Controlling cell differentiation with precision through understanding the structure and dynamics of gene regulatory networks |
v1:2020/05/15 |
NGS (RNA-seq) Microarray |
Illumina (HiSeq 2000/2500) Agilent Technologies (SurePrint G3 Human GE v2 8x60K Microarray, SureScan G4900DA) |
TF-hESCs derived from SEES3 (Cell-line) |
Minoru S.H. Ko |
Controlled-Access (Type I) Unrestricted-access |
JGAS000122 |
Development of hunanized mice for human immunity research |
v1:2020/11/20 |
NGS (Target Capture) |
Illumina (HiSeq 1500/2500) |
118 AMLs (Japanese) |
Fumihiko Ishikawa |
Controlled-Access (Type I) |
JGAS000125 |
Epigenetics analysis of neurodegenerative diseases |
v1:2017/12/11 |
Methylation array |
Illumina (Human Methylation 450K BeadChip) |
30 Alzheimer's disease patients 30 healty controls (Japanese) |
Atsushi Iwata |
Controlled-Access (Type I) |
JGAS000124 |
Genome-wide analysis for biomarker exploration (endometrial cancer) |
v1:2017/12/11 |
NGS (CAGE-seq) Sanger-seq |
Illumina (HiSeq 2500) Thermo Fisher Scientific (ABI) 3500 Genetic Analyzer |
17 endometrial cancer patients (Japanese) |
Yoshihide Hayashizaki |
Controlled-Access (Type I) |
JGAS000126 |
Analysis for mechanism of onset and progress for NASH |
v1:2019/01/31 |
SNP-chip |
Illumina (Human610-Quad BeadChip, HumanCoreExome BeadChip, HumanOmni2.5-Quad BeadChip) |
902 NAFLDs 7672 healty controls (Japanese) |
Fumihiko Matsuda |
Controlled-Access (Type I) |
JGAS000221 DRA011183 DRA011184 DRA011185 |
The genetic analysis of circulating tumor DNA in blood of the digestive cancer patients to investigate the prognostic factors of metastasis and reccurence. |
v1:2020/04/03 v2:2020/10/30 |
NGS (Exome, RNA-seq, Target Capture) |
Illumina (HiSeq 2500) |
10 colorectal cancers (Japanese) |
Koshi Mimori |
Controlled-Access (Type I) Unrestricted-access |
DRA006622 DRA007336 DRA008459 E-GEAD-311 |
Mutation analysis of iPS cells derived from commercially-avaialble human primary cells |
v1:2020/01/14 |
NGS (WGS) SNP-chip |
Illumina (HiSeq X Ten, Infinium Omni2.5-8 v1.4 BeadChip) |
human iPS cells and their parental cells: total 27 samples (Cell-line) |
Ryoko Araki |
Unrestricted-access |
JGAS000129 |
Study for exome sequencing in familial epidermal growth factor receptor-mutant lung cancer |
v1:2018/04/06 |
NGS (Exome) |
Illumina (HiSeq 2000) |
3 EGFR-mutant lung cancers (Japanese) |
Toshiaki Kikuchi (P-DIRECT) |
Controlled-Access (Type I) |
JGAS000127 |
Immune regulation by cotrolling regulatory T cell-specific epigenome |
v1:2018/11/05 |
NGS (RNA-seq) |
Thermo Fisher Scientific (Ion S5) |
3 Crohn's diseases 4 Colorectal cancers (normal cells) (Japanese) |
Shimon Sakaguchi |
Controlled-Access (Type I) |
Identification of the disease and drug susceptibility genes for the Childhood Idiopathic Nephrotic Syndrome |
v1:2018/04/27 v2:2020/09/01 |
SNP-chip |
Affymetrix (Japonica Array v1/v2) |
224 + 3,206 Childhood Idiopathic Nephrotic Syndrome patients 419 + 987 healthy controls (Japanese) |
Kazumoto Iijima |
Unrestricted-access |
|
JGAS000130 |
Implementation of individualized medicine for cancer patients by multiomics-based analyses—the Project HOPE (High-tech Omics-based Patients Evaluation) for Cancer Therapy— |
v1:2020/04/14 |
NGS (Exome) |
Thermo Fisher Scientific (Ion Proton) |
91 cancer patients with hypermutator tumors harborig POLE mutations (Japanese) |
Ken Yamaguchi |
Controlled-Access (Type I) |
JGAS000153 |
A study on comprehensive genome and proteome analyses of the chronic eosinophillic inflammatory diseases. |
v1:2018/10/29 |
NGS (RNA-seq) |
Illumina (HiSeq 2000) |
6 chronic rhinosinusitis with nasal polyps (Japanese) |
Shigeharu Fujieda |
Controlled-Access (Type I) |
JGAS000131 |
Research for analyzing mechanistic insight into disease progression of neural disease based on iPS cell technology |
v1:2018/04/06 |
NGS (ChIP-seq) |
Illumina (HiSeq 2500) |
2 CHARGE syndrome patients (Japanese) |
Hideyuki Okano |
Controlled-Access (Type I) |
JGAS000150 |
Comprehensive genetic analyses of bone marrow cells in POEMS syndrome Analyses of molecular mechanisms of hematological malignancies and bone marrow niche |
v1:2019/01/18 |
NGS (Exome, Target Capture, RNA-seq) |
Illumina (HiSeq 1500/2500, MiSeq) |
20 POEMS syndromes 4 MMs 5 MGUSs (Japanese) |
Emiko Sakaida |
Controlled-Access (Type I) |
JGAS000132 |
The epigenetics of neurodevelopmental disorders |
v1:2018/11/20 |
NGS (RNA-seq) |
Thermo Fisher Scientific (Ion Proton) |
6 Williams syndromes 8 healthy contorols (Japanese) |
Ryo Kimura |
Controlled-Access (Type I) |
JGAS000137 |
Identification of genetic alterations in Vietnamese individuals with elevated blood dioxin level |
v1:2018/09/07 |
NGS (WGS) |
Illumina (HiSeq 2500) |
9 trios of the father exposed to dioxin and his wife and child with mental retardation (total 27 individuals) (Vietnamese) |
Hidewaki Nakagawa |
Controlled-Access (Type I) |
JGAS000086 |
Identification of genetic mutations characteristic for recurrence and metastasis of gastric cancer. |
v1:2018/04/06 |
NGS (Exome) |
Illumina (HiSeq 2000) |
75 gastric cancers (Japanese) |
Toshiharu Yamaguchi (P-DIRECT) |
Controlled-Access (Type I) |
JGAS000087 |
Identification of genetic mutations characteristic for recurrence and metastasis of B cell lymphoma. |
v1:2018/04/06 |
NGS (Exome) |
Illumina (HiSeq 2000) |
60 B cell lymphomas (Japanese) |
Toshiharu Yamaguchi (P-DIRECT) |
Controlled-Access (Type I) |
Construction of integrated clinical genome database regarding hepatitis B related diseases |
v1:2018/05/22 |
SNP-chip |
Affymetrix (Axiom ASI) |
1,193 individuals vaccinated with a HB vaccine (Japanese) |
Masashi Mizokami |
Unrestricted-access |
|
JGAS000144 |
a multicenter study of susceptibility genes to type 1 diabetes |
v1:2018/12/21 |
NGS (Target Capture) |
Thermo Fisher Scientific (Ion Proton) |
32 type 1 diabetes patients (Japanese) |
Hiroshi Ikegami |
Controlled-Access (Type I) |
JGAS000134 |
Clonal structure and oncogenic potential of liver cirrhosis tissues |
v1:2020/07/31 |
NGS (Exome, RNA-seq) |
Illumina (HiSeq 2500/4000) |
Liver cirrhosis: 10 cases Hepatocellular carcinoma: 4 cases (Japanese) |
Atsushi Takai |
Controlled-Access (Type I) |
JGAS000136 |
Research for drug discovery and elucidation of pathophysiology using disease-specific iPS cells |
v1:2018/07/10 |
NGS (Exome) |
Illumina (HiSeq 1500) |
1 RALD patient (Japanese) |
Makoto Otsu |
Controlled-Access (Type I) |
JGAS000158 |
Prediction of response to preoperative chemoradiotherapy in rectal cancer based on whole-exome sequencing and transcriptomic analysis |
v1:2019/11/19 |
NGS (Exome) |
Illumina (HiSeq 2000) |
74 rectal cancer treated with preoperative chemoraidotherapy (Japanese) |
Takashi Akiyoshi |
Controlled-Access (Type I) |
JGAS000135 |
Immune regulation by cotrolling regulatory T cell-specific epigenome |
v1:2019/05/09 |
NGS (RNA-seq) |
Thermo Fisher Scientific (Ion S5) |
Head and neck cancer: 4 cases (Japanese) |
Shimon Sakaguchi |
Controlled-Access (Type I) |
JGAS000147 |
Comprehensive analysis of genetic alterations in hematological malignancies (pediatric B-cell precursor acute lymphoblastic leukemia in Down syndrome) |
v1:2020/01/10 |
NGS (RNA-seq), Methylation array, SNP array |
Illumina (HiSeq 2000/2500, Infinium MethylationEPIC BeadChip, Infinium HumanMethylation450 BeadChip) Affymetrix (GeneChip Human Mapping 250K Nsp, CytoScan HD) |
pediatric B-cell precursor acute lymphoblastic leukemia in Down syndrome: 43 cases (Japanese) |
Junko Takita |
Controlled-Access (Type I) |
JGAS000222 |
The genetic analysis of circulating tumor DNA in blood of the digestive cancer patients to investigate the prognostic factors of metastasis and reccurence. |
v1:2020/04/03 |
NGS (Target Capture) |
Illumina (HiSeq 2500) |
10 colorectal cancers (Japanese) |
Koshi Mimori |
Controlled-Access (Type I) |
DRA007187 |
Diagnosis of imprinting disorders and safety evaluation of assisted reproduction technologies (ART) |
v1:2019/02/19 |
NGS (RRBS) |
Illumina (HiSeq 2500) |
5 SRS patients born after ART 5 spontaneously conceived SRS patients 10 spontaneously conceived children (Japanese) |
Takahiro Arima |
Un-restricted Access |
JGAS000145 |
Immune regulation by cotrolling regulatory T cell-specific epigenome |
v1:2020/05/25 |
NGS (RNA-seq, ChIP-seq, PBAT-seq, ATAC-seq) |
Thermo Fisher Scientific (Ion S5) Illumina (HiSeq 2500, NovaSeq 6000) |
4 healty donors (Japanese) |
Shimon Sakaguchi |
Controlled-Access (Type I) |
JGAS000149 |
Analysis of abnomal character and expression of genes in tissues of urologic carcinomas. |
v1:2019/06/20 |
NGS (RNA-seq) |
Illumina (Genome Analyzer IIx) |
67 renal cell carcinomas (Japanese) |
Takeshi Yuasa |
Controlled-Access (Type I) |
JGAS000182 |
Multi‐institutional study on molcular pathogenesis of bone and soft tissue tumors by genome and proteome analyses and its clinical application |
v1:2019/09/20 |
NGS (Exome, RNA-seq) |
Illumina (HiSeq 2500) |
Dedifferentiated liposarcoma: 37 cases (Japanese) |
Hitoshi Ichikawa |
Controlled-Access (Type I) |
JGAS000177 |
Multiomics analysis of rare cancers to identify genetic alterations related with pathogenesis and prognosis |
v1:2019/09/20 |
NGS (Exome, RNA-seq, Target Capture) |
Illumina (HiSeq 2500, MiSeq) |
28 Dedifferentiated liposarcoma patients 36 Tendon sheath giant cell tumor patient (Japanese) |
Koichi Matsuda |
Controlled-Access (Type I) |
JGAS000164 |
Cancer clinical sequence and accompanying research for comprehensive genomic and epigenomic analyses |
v1:2019/08/19 |
NGS (Target Capture) |
Illumina (NextSeq) |
183 cancer patients (Japanese) |
Kohei Miyazono |
Controlled-Access (Type I) |
JGAS000151 |
Genome sequencing analysis for liver cancer |
v1:2018/10/22 v2:2019/06/21 |
NGS (WGS, RNA-seq) |
Illumina (HiSeq 2000, Genome Analyzer IIx, NovaSeq 6000) |
263 liver cancers (Japanese) |
Hidewaki Nakagawa |
Controlled-Access (Type I) |
JGAS000155 |
Genome sequencing analysis for esophageal squamous cell carcinoma |
v1:2019/05/28 |
NGS (WGS) |
Illumina (HiSeq 2000/2500/X Five) |
20 esophageal squamous cell carcinomas (Japanese) |
Hidewaki Nakagawa |
Controlled-Access (Type I) |
Pharmacogenomics research for therapeutics in psychiatry, neurology and oncology |
v1:2018/12/14 |
NGS (Target Capture) |
Illumina (MiSeq) |
990 patients with psychiatric/neurological disorders and cancers (Japanese) |
Taisei Mushiroda |
Unrestricted-access |
|
JGAS000160 |
Tohoku Medical Megabank Organization cohort study |
v1:2018/12/14 |
SNP-chip |
Illumina (Infinium OmniExpressExome-8) |
9,187 participants (Japanese) |
Masao Nagasaki |
Controlled-Access (Type I) |
JGAS000162 |
Genetic analysis of familial myelodysplastic syndromes |
v1:2019/05/07 |
NGS (Exome) |
Illumina (HiSeq 2500) |
2 patients of familial myelodysplastic syndromes (Japanese) |
Junji Koya |
Controlled-Access (Type I) |
Multicenter Evaluation of NUDT15-R139C genotyping efficiency to DEtect thiopurine-induced hair Loss and leukopenia (MENDEL study) |
v1:2019/07/30 |
SNP-chip |
Affymetrix (Japonica Array v1) |
1221 patients of Inflammatory bowel disease (Japanese) |
Yoichi Kakuta |
Unrestricted-access |
|
Study to clarify the pathophysiology of gout / hyperuricemia and uric acid related diseases |
v1:2019/07/23 |
SNP-chip |
Illumina (HumanOmniExpressExome-8, 660W-Quad, Omni2.5-8, OmniExpress-12, OmniExpress-24, HumanOmniExpressExome, HumanOmniExpress, HumanExome BeadChip) |
121,745 participants of 3 Japanese cohorts (J-MICC study, KING study, BBJ) (Japanese) |
Hirotaka Matsuo |
Unrestricted-access |
|
JGAS000169 |
Comprehensive genomic analyses of cancers |
v1:2019/11/08 |
NGS (Exome) |
Illumina (HiSeq 2500) |
51 adenomyosis patients (Japanese) |
Masahito Kawazu |
Controlled-Access (Type I) |
JGAS000178 |
Molecular analysis to identify novel biomarker and therapeutic target for cerebrospinal tumor and preclinical investigation using patient derived orthotopic xenograft models. |
v1:2019/06/01 v2:2020/07/17 |
NGS (Exome) |
Illumina (HiSeq 2500) |
9 PCNSL patinets (Japanese) |
Tetsuya Yamamoto |
Controlled-Access (Type I) |
JGAS000171 |
A Study on the Health and Development of Children Beginning in the Fetal Period |
v1:2019/04/23 |
NGS (RRBS) |
Illumina (NextSeq) |
human umbilical cords: 30 samples (Japanese) |
Chisato Mori |
Controlled-Access (Type I) |
JGAS000173 |
Building a Database of Genomic Structural Variants in Japanese population |
v1:2020/10/06 v2:2020/11/27 |
NGS (WGS) |
PacBio (Sequel) 10x Genomics (Chromium Controller) |
Purified DNA from Japanese-origin B cell liens: 10 + 11 samples |
Shinichi Morishita |
Controlled-Access (Type I) |
JGAS000174 |
Development of actionable molecular targets and/or biomarkers for prognostication and patient stratification in gynecological cancer based on whole-exome sequencing and epigenomic analysis |
v1:2019/10/02 |
NGS (Exome) |
Illumina (HiSeq 2000) |
69 endometrial carcinomas (Japanese) |
Nobuhiro Takeshima |
Controlled-Access (Type I) |
JGAS000172 |
Comprehensive sequencing analyses of uterine and ovarian carcinosarcoma |
v1:2019/10/02 |
NGS (Exome, Target Capture) |
Illumina (HiSeq 2000) |
92 uterine carcinosarcomas 17 ovarian carcinosarcomas (Japanese) |
Seiichi Mori |
Controlled-Access (Type I) |
JGAS000197 |
Genetic analysis assciated with malignance of brain tumor |
v1:2020/04/27 |
NGS (WGBS, RNA-seq, ChIP-seq) |
Illumina (HiSeq X Ten, NovaSeq 6000) |
14 malignant gliomas (Japanese) |
Takashi Ito |
Controlled-Access (Type I) |
JGAS000186 DRA009794 |
Shotgun metagenome analysis of oral microbiome in MRONJ and healthy individuals |
v1:2020/04/03 |
Metagenome |
Nanopore (PromethION) Illumina (HiSeq) |
4 healthy individuals (Japanese) |
Koji Yahara (Genome Science) |
Controlled-Access (Type I) Unrestricted-access |
Aging of steroid production in the adrenal bland. |
v1:2019/09/25 |
Immunohistochemistry |
Dako (Autostainer Link 48) |
85 anatomical cases who were more than 50 years old (Japanese) |
Koshiro Nishimoto |
Unrestricted-access |
|
JGAS000180 DRA008482 |
Comprehansive analysis of somatic mutations and genetic variations with whole genome sequencing |
v1:2019/06/20 v2:2020/05/12 |
NGS (WGS) |
Nanopore (MinION) Illumina (HiSeq 2000, Genome Analyzer IIx) |
liver cancer (normal cell): 174 case HapMap: 1 sample (Japanese) |
Akihiro Fujimoto |
Controlled-Access (Type I) Unrestricted-access |
JGAS000239 |
Construction of Japanese Whole-Genome database |
v1:2020/09/01 |
NGS (WGS) |
Illumina (HiSeq 2500, NovaSeq 6000) |
4,566 general residents (Japanese) |
Masayuki Yamamoto |
Controlled-Access (Type II) |
JGAS000194 |
Genomic and genetic analysis of digestive tract cancer and elucidation of its clinicopathological significance. |
v1:2020/05/12 |
NGS (Target Capture) |
Illumina (MiSeq) |
243 hepatocellular carcinomas (Japanese) |
Hiroyuki Aburatani |
Controlled-Access (Type I) |
JGAS000179 |
Exploration for molecular targets in gastric cancer cell lines |
v1:2019/06/28 |
NGS (Exome, RNA-seq) |
Illumina (HiSeq 2500) |
2 gastric cancer cell lines (Cell-line) |
Hiroyuki Mano |
Controlled-Access (Type I) |
DRA008575 |
Development of personalized cancer vaccine targeting individual somatic mutations combined with immunoregulation of tumor microenvironment |
v1:2020/06/05 |
NGS (RNA-seq) |
Illumina (HiSeq 1500/4000) |
Pancreatic cancer: 17 cases (Japanese) |
Kazuhiro Kakimi |
Unrestricted-access |
JGAS000189 |
Molecular mechanisms of drug resistance in cancer |
v1:2020/05/11 |
NGS (Target Capture) |
Illumina (MiSeq) |
2 lung adenocarcinomas (Japanese) |
Ryohei Katayama |
Controlled-Access (Type I) |
Identification of biomarker for suicide prevention using blood and brain samples of completed suicide |
v1:2019/12/20 |
SNP-chip |
Illumina (HumanOmniExpress-24 BeadChip, HumanOmniExpressExome-8 BeadChip) |
Suicide: 746 cases Non-suicide: 14,049 cases (Japanese) |
Akitoyo Hishimoto |
Unrestricted-access |
|
JGAS000205 JGAS000260 |
Elucidation of disease state by multi-layered omics analysis |
v1:2019/11/15 v2:2020/11/27 |
Metagenome SNP-chip |
Illumina (HiSeq 3000, Infinium Asian Screening Array) |
95 + 103 individuals Autoimmune pulmonary alveolar proteinosis: 198 cases 395 Healthy controls (Japanese) |
Yukinori Okada |
Controlled-Access (Type I) Unrestricted-access |
JGAS000198 |
Identification of therapeutic target molecules in urological malignancies by using next generation sequencer |
v1:2020/06/29 |
NGS (RNA-seq) |
Illumina (HiSeq 2500) |
Prostate cancer: 25 cases (Japanese) |
Tetsuya Fujimura |
Controlled-Access (Type I) |
JGAS000199 JGAS000237 JGAS000256 |
Collection and transfer of human tumor samples and research using genomic information Transfer of existing samples and research using genomic information Reseach of searching gene mutations in gastrointestinal chronic inflammatory diseases |
v1:2019/12/20 v2:2020/10/06 v3:2020/11/20 |
NGS (Exome, WGS, RNA-seq) |
Illumina (HiSeq 2500/4000, NovaSeq 6000) |
gastrointestinal inflammatory disease: 29 cases gastrointestinal inflammatory disease with neoplastic disease: 26 cases control patients who underwent colonoscopy: 16 individuals neoplastic disease: 23 + 1 cases (Japanese) |
Toshiro Sato |
Controlled-Access (Type I) |
JGAS000206 |
Establishment of an integrated database for clinical and genomic data in cancer |
v1:2020/06/01 |
NGS (Target Capture) |
Illumina (HiSeq 2500) |
154 patients with multiple myeloma (Japanese) |
Keizo Horibe |
Controlled-Access (Type I) |
JGAS000207 |
Establishment and characterization of cell lines derived from pregnancy related diseases |
v1:2019/11/26 |
NGS (WGBS, RNA-seq) |
Illumina (HiSeq 1500/2500) |
complete hydatidiform mole: 3 cases (Japanese) |
Takahiro Arima |
Controlled-Access (Type I) |
Analysis of gene polymorphism and gene expression in human immune cells |
v1:2020/01/06 |
NGS (RNA-seq, ChIP-seq, Hi-C) eQTL |
Illumina (HiSeq 2500, HiSeq series, Infinium OmniExpressExome BeadChips) |
rheumatoid arthritis: 30 cases osteoarthritis: 30 cases (Japanese) |
Keishi Fujio |
Unrestricted-access |
|
JGAS000214 |
Comprehensive genetic analysis and database construction for head and neck cancer |
v1:2020/01/20 |
NGS (Exome) |
Illumina (HiSeq X Ten) |
10 patients with cancer of the external auditory canal (Japanese) |
Takashi Nakagawa |
Controlled-Access (Type I) |
Genetic and clinical prediction models for the efficacy and hepatotoxicity of methotrexate in patients with rheumatoid arthritis: a multicenter cohort study |
v1:2019/12/13 |
SNP-chip Direct sequencing |
Thermo Fisher Scientific (GeneChip® Scanner 3000 7G) Applied Biosystems (Veriti 96-Well Thermal Cycler and 3730XL DNA Analyzer) |
Rheumatoid arthritis: 166 cases (Japanese) |
Shunichi Kumagai |
Unrestricted-access |
|
JGAS000211 |
Comprehensive genomic analysis of hematological malignancies |
v1:2020/04/06 |
NGS (Exome) |
Illumina (NextSeq 500) |
1 patient with concomitant acute myeloid leukemia and mediastinal germ cell tumor (Japanese) |
Kazuya Shimoda |
Controlled-Access (Type I) |
JGAS000220 |
Integrative understanding of human immune system by functional genomics and development of intervention strategies for the prevention of autoimmune diseases |
v1:2020/10/09 |
NGS (RNA-seq) |
Illumina (HiSeq 2500) |
Systemic sclerosis: 21 cases 13 normal controls (Japanese) |
Keishi Fujio |
Controlled-Access (Type I) |
JGAS000216 JGAS000244 |
Investigation of anti-tumor immunological response in solid tumors |
v1:2020/02/07 v2:2020/09/25 |
NGS (Exome) |
Illumina (HiSeq 2500) |
17 patients with lung adenocarcinoma 26 patients with gastric cancer 9 patients with lung cancer 5 patients with malignant melanoma (Japanese) |
Hiroyoshi Nishikawa |
Controlled-Access (Type I) |
JGAS000217 |
Identification of genetic alterations predicting cancer progression from colorectal polyps |
v1:2020/03/02 |
NGS (Target Capture) |
Thermo Fisher Scientific (Ion Torrent) |
50 colorectal serrated lesions (Japanese) |
Takeshi Sawada |
Controlled-Access (Type I) |
E-GEAD-344 |
Gene expression analysis in systemic sclerosis |
v1:2020/10/09 |
NGS (scRNA-seq) |
Illumina (HiSeq) |
Systemic sclerosis: 3 cases (Japanese) |
Keishi Fujio |
Unrestricted-access |
JGAS000223 |
A study of influence of storage condition after blood collection on the plasma/serum comcentrations of compounds |
v1:2020/06/02 |
LC-MS/MS |
Sciex (TripleTOF 5600) |
3 heathy individuals (Japanese) |
Sumio Ohtsuki (AMED-Metabolites) |
Controlled-Access (Type I) |
JGAS000224 |
Identification of responsible genes and development of standardized medicine for familial breast cancer by genetic analysis with NGS technology |
v1:2020/03/13 |
NGS (Target Capture) |
Illumina (HiSeq 2000) |
115 breast cancer patients (Japanese) |
Shinji Ohno |
Controlled-Access (Type I) |
JGAS000232 |
The analyses of gene mutations in hematology malignancy |
v1:2020/09/01 |
NGS (Target Capture) |
Thermo Fisher Scientific (Ion Proton) |
7 patients with multiple myeloma (Japanese) |
Yasuhito Terui |
Controlled-Access (Type I) |
JGAS000226 |
Mortality and risk of progression to adult T-cell leukemia/lymphoma in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis |
v1:2020/05/08 |
NGS (Target Capture) |
Illumina (HiSeq 2500/3000) |
HAM: 21 cases (Japanese) |
Makoto Yamagishi |
Controlled-Access (Type I) |
JGAS000230 |
Identification and characterization of molecular markers in aging and neuronal disorders |
v1:2020/05/15 |
NGS (scRNA-seq) |
Illumina (HiSeq 2500) |
7 supercentenarians 2 family members 2 unrelated donors (Japanese) |
Piero Carninci |
Controlled-Access (Type I) |
JGAS000231 |
Evaluation of metastasis and recurrence by monitoring circulating tumor DNA of gastric cancer |
v1:2020/06/01 |
NGS (Target Capture) |
Illumina (HiSeq 2000) |
10 gastric cancer patients (Japanese) |
Satsoshi Nishizuka |
Controlled-Access (Type I) |
JGAS000245 |
Development of tumor infiltrating lymphocytes therapy targeting gene mutation of lung cancer |
v1:2020/12/14 |
NGS (Exome, RNA-seq) |
Illumina (HiSeq 2500) Nanopore (MinION) |
7 non-small cell lung cancer patients (Japanese) |
Tetsuya Nakatsura |
Controlled-Access (Type I) |
JGAS000240 |
Development of personalized medicine |
v1:2020/07/28 |
NGS (WGS) |
Illumina (HiSeq 2500) |
3 participants of BBJ (Japanese) |
Yukihide Momozawa |
Controlled-Access (Type I) |
JGAS000241 |
Genomic and Proteomic comprehensive analysis related to cancer, infectious diseases, intractable diseases and lifestyle-related diseases |
v1:2020/07/27 |
NGS (Target Capture) |
Thermo Fisher Scientific (Ion Proton) |
19 patients with urothelial bladder cancer (Japanese) |
Yosuke Hirotsu |
Controlled-Access (Type I) |
JGAS000258 |
Whole genome sequence analysis in patients with primary central nervous system lymphomas |
v1:2020/10/30 |
NGS (Target Capture) |
Thermo Fisher Scientific (Ion Torrent) |
28 PCNSL patinets (Japanese) |
Ryuya Yamanaka |
Controlled-Access (Type I) |
JGAS000243 |
Frequent post-treatment monitoring of colorectal cancer using individualized ctDNA validated by multi-regional molecular profiling |
v1:2021/01/05 |
NGS (Target Capture) |
Illumina (HiSeq 2000) |
12 colorectal cancer patients (Japanese) |
Satsoshi Nishizuka |
Controlled-Access (Type I) |
JGAS000253 |
Development of humanized mice for human immunity research/Construction of disease and treatment model using iPS cells derived from human hematopoitec cells. |
v1:2020/11/20 |
NGS (RNA-seq, CAGE-seq) |
Illumina (HiSeq 2500) |
Cord blood: 24 individuals Acute Myeloid Leukemia: 116 cases (Japanese) |
Fumihiko Ishikawa |
Controlled-Access (Type I) |
JGAS000249 DRA010773 |
Research for gene mutations in cancer representing immune status of the patients |
v1:2021/01/04 |
NGS (Exome) |
Illumina (HiSeq 1500) |
3 malignant melanoma patients (Japanese) |
Takashi Iwata |
Controlled-Access (Type I) Unrestricted-access |
JGAS000259 |
Establishment of a Japanese reference genome sequence by high-precision long-read sequencing |
v1:2020/10/30 v2:2020/11/06 |
NGS (WGS) |
PacBio (RS II) Bionano (Irys, Saphyr) Illumina (HiSeq 2500) |
3 Japanese male individuals (Japanese) |
Masayuki Yamamoto |
Unrestricted-access Controlled-Access (Type II) |
JGAS000248 |
Elucidation of pathological conditions and development of therapeutic methods using iPS cells derived from patients with hard tissue/connective tissue related diseases |
v1:2020/09/01 |
NGS (CAGE-seq) |
Illumina (NextSeq 500) |
3 patients with hard tissue/connective tissue related diseases (Japanese) |
Toshifumi Azuma |
Controlled-Access (Type I) |
Genome-wide association study of primary biliary cholangitis (PBC) -an additional study of 1,000 Japanese PBC patients- |
v1:2021/01/08 v2:2021/01/19 |
SNP-chip |
Affymetrix (Axiom Genome-Wide ASI 1 Array, Japonica Array v1) |
1,953 PBCs and 3,690 healthy controls (Japanese) |
Minoru Nakamura |
Unrestricted-access |
# You can search the data in the European Sequence Read Archive (ERA) and the Sequence Read Archive (SRA) through the DDBJ Sequence Read Archive (DRA) site.
# You can also search the data in SRA through the Database Center for Life Science (DBCLS) SRA web site.